Imovax® Rabies and VERORAB® Immunogenicity and Safety After One Week 2-sites Intradermal or 1-site Intramuscular Pre-Exposure Prophylaxis Regimens, Followed by a Simulated Post-Exposure Prophylaxis Regimen at One Year

NCT03700242 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

570

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers (Rabies Immunization)

Interventions

BIOLOGICAL: HDCV
BIOLOGICAL: HDCV
BIOLOGICAL: PVRV
BIOLOGICAL: PVRV

Sponsor

Sanofi Pasteur, a Sanofi Company